시장보고서
상품코드
1420953

보조생식기술(ART) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Assisted Reproductive Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 189 Pages | 배송안내 : 2-10일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보조생식기술(ART) 시장 - 보고서의 범위

TMR의 세계 보조생식기술(ART) 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 전 세계 보조생식기술(ART) 수익에 대한 정보를 제공합니다. 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 2017년부터 2031년까지 시장을 분석합니다. 이 보고서는 2023년부터 2031년까지 세계 보조생식기술(ART) 시장의 연평균 복합 성장률(CAGR%)도 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 주요 오피니언 리더, 업계 리더 및 오피니언 제조업체를 인터뷰하는 분석가가 주요 오피니언 리더, 업계 리더 및 오피니언 제조업체를 인터뷰하는 1차 조사, 보조 보조생식기술 시장을 이해하기 위해 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조, 연례 보고서, 보도 자료 및 관련 문서에 대한 참조를 포함합니다.

시장 현황
2023년 시장 가치 259억 달러
2031년 시장 가치 586억 달러
CAGR 9.4%

이 보고서는 세계 보조생식기술(ART) 시장 경쟁 구도를 심층적으로 분석합니다. 세계 보조생식기술(ART) 시장에서 활동하는 주요 기업들이 확인되었으며, 이들 각각은 다양한 속성 측면에서 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 보조생식기술(ART) 시장의 기업 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계 시장 분석과 예측, 2017년-2031년

제5장 주요 인사이트

  • 파이프라인 분석
  • 주요 기술 브랜드 분석
  • 주요 합병과 인수
  • COVID-19 감염증 팬데믹이 업계에 미치는 영향

제6장 세계 시장 분석과 예측 : 기술별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 기술별, 2017년-2031년
    • 체외수정
      • 세포질내 정자 주입(ICSI)
      • 착상전 유전자 진단(PGD)
    • 인공수정
      • 자궁내 수정(IUI)
      • 자궁경관내 수정(ICI)
      • 기타
    • 대리 출산
    • 기타
  • 시장 매력 분석 : 기술별

제7장 세계 시장 분석과 예측 : 시술별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 시술별, 2017년-2031년
    • 동결 기증자
    • 동결 비기증자
    • 신선 기증자
    • 신선 비기증자
    • 배아 은행
  • 시장의 매력 분석 : 시술별

제8장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 최종사용자별, 2017년-2031년
    • 불임 클리닉
    • 병원
    • 기타
  • 시장의 매력 분석 : 최종사용자별

제9장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 매출 예측 : 지역별, 2017년-2031년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 분석 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
  • 시장 점유율 분석 : 기업별(2022년)
  • 기업 개요
    • Merck KGaA
    • CooperSurgical, Inc.
    • FUJIFILM Irvine Scientific
    • Vitrolife AB
    • Hamilton Thorne, Inc.
    • Nikon Corporation
    • Nidacon International AB
    • Laboratoire CCD
    • Esco Micro Pte. Ltd.
LSH 24.02.15

Assisted Reproductive Technology Market - Scope of Report

TMR's report on the global assisted reproductive technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global assisted reproductive technology market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global assisted reproductive technology market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the assisted reproductive technology market.

Market Snapshot
Market Value in 2023US$ 25.9 Bn
Market Value in 2031US$ 58.6 Bn
CAGR9.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global assisted reproductive technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global assisted reproductive technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global assisted reproductive technology market.

The report delves into the competitive landscape of the global assisted reproductive technology market. Key players operating in the global assisted reproductive technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global assisted reproductive technology market profiled in this report.

Key Questions Answered in Global assisted reproductive technology Market Report:

  • What is the sales/revenue generated by assisted reproductive technology across all regions during the forecast period?
  • What are the opportunities in the global assisted reproductive technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Assisted Reproductive Technology Market - Research Objectives and Research Approach

The comprehensive report on the global assisted reproductive technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global assisted reproductive technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global assisted reproductive technology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Assisted Reproductive Technology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2017-2031
    • 6.3.1. In Vitro Fertilization
      • 6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 6.3.2. Artificial Insemination
      • 6.3.2.1. Intrauterine Insemination (IUI)
      • 6.3.2.2. Intracervical Insemination (ICI)
      • 6.3.2.3. Others
    • 6.3.3. Surrogacy
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Technology

7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Procedure, 2017-2031
    • 7.3.1. Frozen Donor
    • 7.3.2. Frozen Non-donor
    • 7.3.3. Fresh Donor
    • 7.3.4. Fresh Non-donor
    • 7.3.5. Embryo Banking
  • 7.4. Market Attractiveness Analysis, by Procedure

8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Fertility Clinics
    • 8.3.2. Hospitals
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Assisted Reproductive Technology Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Technology, 2017-2031
    • 10.3.1. In Vitro Fertilization
      • 10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 10.3.2. Artificial Insemination
      • 10.3.2.1. Intrauterine Insemination (IUI)
      • 10.3.2.2. Intracervical Insemination (ICI)
      • 10.3.2.3. Others
    • 10.3.3. Surrogacy
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Procedure, 2017-2031
    • 10.4.1. Frozen Donor
    • 10.4.2. Frozen Non-donor
    • 10.4.3. Fresh Donor
    • 10.4.4. Fresh Non-donor
    • 10.4.5. Embryo Banking
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Fertility Clinics
    • 10.5.2. Hospitals
    • 10.5.3. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Technology
    • 10.7.2. By Procedure
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Assisted Reproductive Technology Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Technology, 2017-2031
    • 11.3.1. In Vitro Fertilization
      • 11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 11.3.2. Artificial Insemination
      • 11.3.2.1. Intrauterine Insemination (IUI)
      • 11.3.2.2. Intracervical Insemination (ICI)
      • 11.3.2.3. Others
    • 11.3.3. Surrogacy
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Procedure, 2017-2031
    • 11.4.1. Frozen Donor
    • 11.4.2. Frozen Non-donor
    • 11.4.3. Fresh Donor
    • 11.4.4. Fresh Non-donor
    • 11.4.5. Embryo Banking
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Fertility Clinics
    • 11.5.2. Hospitals
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Technology
    • 11.7.2. By Procedure
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. In Vitro Fertilization
      • 12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 12.3.2. Artificial Insemination
      • 12.3.2.1. Intrauterine Insemination (IUI)
      • 12.3.2.2. Intracervical Insemination (ICI)
      • 12.3.2.3. Others
    • 12.3.3. Surrogacy
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Procedure, 2017-2031
    • 12.4.1. Frozen Donor
    • 12.4.2. Frozen Non-donor
    • 12.4.3. Fresh Donor
    • 12.4.4. Fresh Non-donor
    • 12.4.5. Embryo Banking
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Fertility Clinics
    • 12.5.2. Hospitals
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Technology
    • 12.7.2. By Procedure
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Assisted Reproductive Technology Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. In Vitro Fertilization
      • 13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 13.3.2. Artificial Insemination
      • 13.3.2.1. Intrauterine Insemination (IUI)
      • 13.3.2.2. Intracervical Insemination (ICI)
      • 13.3.2.3. Others
    • 13.3.3. Surrogacy
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Procedure, 2017-2031
    • 13.4.1. Frozen Donor
    • 13.4.2. Frozen Non-donor
    • 13.4.3. Fresh Donor
    • 13.4.4. Fresh Non-donor
    • 13.4.5. Embryo Banking
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Fertility Clinics
    • 13.5.2. Hospitals
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Technology
    • 13.7.2. By Procedure
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. In Vitro Fertilization
      • 14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 14.3.2. Artificial Insemination
      • 14.3.2.1. Intrauterine Insemination (IUI)
      • 14.3.2.2. Intracervical Insemination (ICI)
      • 14.3.2.3. Others
    • 14.3.3. Surrogacy
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Procedure, 2017-2031
    • 14.4.1. Frozen Donor
    • 14.4.2. Frozen Non-donor
    • 14.4.3. Fresh Donor
    • 14.4.4. Fresh Non-donor
    • 14.4.5. Embryo Banking
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Fertility Clinics
    • 14.5.2. Hospitals
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Technology
    • 14.7.2. By Procedure
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. CooperSurgical, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. FUJIFILM Irvine Scientific
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Vitrolife AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Hamilton Thorne, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Nikon Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Nidacon International AB
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Laboratoire CCD
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Esco Micro Pte. Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Technology Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제